Cytek Biosciences, Inc. (CTKB) financial statements and ratios from SEC XBRL: revenue $201.49M (TTM), net margin -33.0%, revenue growth 0.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $201.49M |
| Net Margin | -33.0% |
| Revenue Growth (YoY) | 0.5% |
| FCF Growth (YoY) | -140.1% |
| Price / Book | 1.88 |
| Price / Sales | 3.21 |
| FCF Yield | -3.7% |
| Altman Z-Score | 3.65 (safe) |
| Sector P/E (Technology) | 33.9 |
CTKB overview · CTKB earnings · CTKB KPIs · CTKB investor relations · CTKB ownership · CTKB peers · CTKB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.